Aclidinium

BNF:: 3.1
Status:: Grey
Decision Date:: June 2015

Comments

GREY 3rd line LAMA:

Eklira Genuair (DPI) (Decision date - August 19)

Brown Drug Classifications

1: Lack of data on effectiveness compared with standard therapy
2: Lack of data on safety compared with standard therapy